Skip to search formSkip to main contentSkip to account menu

dihydrobunolol

Known as: 1-Naphthalenol, 5-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-1,2,3,4-tetrahydro-, dihydrolevobunolol 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Although ocular transport and delivery have been well studied, metabolism in the eye is not well documented, even for clinically… 
2012
2012
SummarySynopsisLevobunolol1 is a potent non-selective β-adrenoceptor blocking agent used for the topical treatment of increased… 
1991
1991
The objective of this study was to determine which of the five or six corneal epithelial layers was rate-limiting in the corneal… 
1988
1988
The distribution of ketone reductase activity in the anterior segment tissues of the pigmented rabbit eye and its influence on… 
1987
1987
The ocular and systemic disposition of levobunolol (LBUN), an antiglaucoma agent, was studied in albino rabbits. After topical… 
1987
1987
ABSTRACT The ocular β-adrenoceptor antagonist activity of dihydrolevobunolol (DHLB), the major ocular and systemic metabolite of… 
1987
1987
The ocular beta-adrenoceptor antagonist activity of dihydrolevobunolol (DHLB), the major ocular and systemic metabolite of… 
1984
1984
Binding of 3H-dihydroalprenolol (3H-DHA) to beta-adrenoceptors in homogenates from rat and rabbit lung was homogeneous and of… 
1977
1977
The metabolism of I‐bunolol, a new f3‐blocking drug, was studied in man after single oral 3‐mg doses of W‐labeled compound… 
1972
1972
1. Cell-free preparations from human liver taken at autopsy were used to biosynthesize a metabolite from bunolol. The metabolite…